Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP
India is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum Institute of India emergency use approval for the Oxford-AstraZeneca vaccine candidate soon after it gets similar approval in the UK. The government, which will make bulk purchases, has also negotiated a better price — almost half that of the likely MRP of Rs 500-600 for the two-shot vaccine.
You Might Like
💡 newsR Knowledge: Other News Mentions
Govt has spent only 20 paisa per month to treat 15 crore people suffering from mental health: Madras high court
25% of PM-Kisan beneficiaries are women: Govt dataNearly one-fourth of beneficiaries under the PM Kisan scheme, launched last year and which was utilised during the lockdown to offer relief to agriculturists,..
Foreign Office minister Baroness Sugg resigns over foreign aid cuts
Credit: PA - Press Association STUDIO Duration: 00:49Published
Govt approves joint military logistics nodes in run-up to theatre commandsThe government has now formally approved the first set of joint structures to handle logistics in the 15-lakh strong armed forces, in a step towards injecting..
Credit: FRANCE 24 English Duration: 03:36Published
India to enhance bilateral ties with Seychelles in post-Covid era: JaishankarIndia has vowed to further enhance its strategic partnership with Seychelles in the post-COVID era as External Affairs Minister S Jaishankar held high-level..
Covid-19 caseload in India climbs to 93,92,919India's Covid-19 caseload inched closer to the 94-lakh mark, while the number of people who have recuperated from the disease crossed 88 lakh pushing the..
Uttarakhand travel guidelines: COVID-19 test mandatory for people coming from DelhiThe Uttarakhand Police on Saturday announced that they would monitor details of the movement of people from other states to Uttarakhand.
Delhi Half Marathon flagged off at JLN Stadium amid poor air quality
Credit: ANI Duration: 01:38Published
‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla
Credit: HT Digital Content Duration: 04:05Published
Centre may purchase 300-400 mn vaccine doses by July 2021, says SII's Poonawalla after PM Modi's visitPoonawalla also disclosed that the SII will apply for emergency authorisation of the COVID-19 vaccine 'Covishield' in the next two weeks.
PM Modi visits vaccine plants in 3 cities, reviews progressPrime Minister Narendra Modi on Saturday visited the units of three vaccine manufacturers in India to review the progress of vaccine development and..
COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India
Credit: ANI Duration: 01:25Published
Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityPrime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's..
Vaccine tour: PM Modi arrives at SII in Pune to review COVID-19 vaccine developmentThe Serum Institute of India has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine.
Wall Street too giddy over vaccines: economist
Credit: Reuters Studio Duration: 05:13Published
Related news from verified sources